{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:25:37Z","timestamp":1793755537648,"version":"4.6.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T00:00:00Z","timestamp":1686355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T00:00:00Z","timestamp":1686355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["215490\/Z\/19\/Z"],"award-info":[{"award-number":["215490\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["215490\/Z\/19\/Z"],"award-info":[{"award-number":["215490\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["215490\/Z\/19\/Z"],"award-info":[{"award-number":["215490\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["215490\/Z\/19\/Z"],"award-info":[{"award-number":["215490\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["215490\/Z\/19\/Z"],"award-info":[{"award-number":["215490\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The World Health Organization published the preferred product characteristics for a Group A\n                    <jats:italic>Streptococcus<\/jats:italic>\n                    (Strep A) vaccine in 2018. Based on these parameters for the age of vaccination, vaccine efficacy, duration of protection from vaccine-derived immunity, and vaccination coverage, we developed a static cohort model to estimate the projected health impact of Strep A vaccination at the global, regional, and national levels and by country-income category. We used the model to analyse six strategic scenarios. Based on Strep A vaccine introduction between 2022 and 2034 for the primary scenario, we estimated vaccination at birth for 30 vaccinated cohorts could avert 2.5 billion episodes of pharyngitis, 354 million episodes of impetigo, 1.4 million episodes of invasive disease, 24 million episodes of cellulitis, and 6 million cases of rheumatic heart disease globally. Vaccination impact in terms of burden averted per fully vaccinated individual is highest in North America for cellulitis and in Sub-Saharan Africa for rheumatic heart disease.\n                  <\/jats:p>","DOI":"10.1038\/s41541-023-00668-0","type":"journal-article","created":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T02:01:43Z","timestamp":1686362503000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Modeling the potential health impact of prospective Strep A vaccines"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6302-506X","authenticated-orcid":false,"given":"Fiona","family":"Giannini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1321-9605","authenticated-orcid":false,"given":"Jeffrey W.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1853-0651","authenticated-orcid":false,"given":"Daniel","family":"Cadarette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah C.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Carapetis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0563-1576","authenticated-orcid":false,"given":"Kaja","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,10]]},"reference":[{"key":"668_CR1","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","volume":"5","author":"JR Carapetis","year":"2005","unstructured":"Carapetis, J. R., Steer, A. C., Mulholland, E. K. & Weber, M. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5, 685\u2013694 (2005).","journal-title":"Lancet Infect. Dis."},{"key":"668_CR2","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1056\/NEJMoa1603693","volume":"377","author":"DA Watkins","year":"2017","unstructured":"Watkins, D. A. et al. Global, regional, and national burden of rheumatic heart disease, 1990\u20132015. N. Engl. J. Med. 377, 713\u2013722 (2017).","journal-title":"N. Engl. J. Med."},{"key":"668_CR3","first-page":"1","volume":"368","author":"AP Ralph","year":"2012","unstructured":"Ralph, A. P. & Carapetis, J. R. Group A Streptococcal diseases and their global burden. Microbiol Immunol. 368, 1\u201327 (2012).","journal-title":"Microbiol Immunol."},{"key":"668_CR4","unstructured":"Sims Sanyahumbi, A., Colquhoun, S., Wyber, R. & Carapetis, J. R. in Streptococcus pyogenes: Basic Biology to Clinical Manifestations (eds. Ferretti, J. J., Stevens, D. L. & Fischetti, V. A.) (University of Oklahoma Health Sciences Center, 2016)."},{"key":"668_CR5","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.clineuro.2013.06.017","volume":"115","author":"D Wang","year":"2013","unstructured":"Wang, D. et al. Stroke and rheumatic heart disease: a systematic review of observational studies. Clin. Neurol. Neurosurg. 115, 1575\u20131582 (2013).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"668_CR6","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1161\/CIRCULATIONAHA.108.836510","volume":"120","author":"G Karthikeyan","year":"2009","unstructured":"Karthikeyan, G. & Mayosi, B. M. Is primary prevention of rheumatic fever the missing link in the control of rheumatic heart disease in Africa? Circulation 120, 709\u2013713 (2009).","journal-title":"Circulation"},{"key":"668_CR7","doi-asserted-by":"publisher","first-page":"250","DOI":"10.5694\/mja2.50318","volume":"211","author":"J Cannon","year":"2019","unstructured":"Cannon, J., Bessarab, D. C., Wyber, R. & Katzenellenbogen, J. M. Public health and economic perspectives on acute rheumatic fever and rheumatic heart disease. Med. J. Aust. 211, 250\u2013252.e1 (2019).","journal-title":"Med. J. Aust."},{"key":"668_CR8","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/cid\/ciw248","volume":"63","author":"GE Nelson","year":"2016","unstructured":"Nelson, G. E. et al. Epidemiology of invasive group A Streptococcal infections in the United States, 2005\u20132012. Clin. Infect. Dis. 63, 478\u2013486 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"668_CR9","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1001\/jama.2016.8825","volume":"316","author":"AB Raff","year":"2016","unstructured":"Raff, A. B. & Kroshinsky, D. Cellulitis: a review. JAMA 316, 325\u2013337 (2016).","journal-title":"JAMA"},{"key":"668_CR10","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.cmi.2018.01.024","volume":"24","author":"J Cannon","year":"2018","unstructured":"Cannon, J., Rajakaruna, G., Dyer, J., Carapetis, J. & Manning, L. Severe lower limb cellulitis: defining the epidemiology and risk factors for primary episodes in a population-based case-control study. Clin. Microbiol. Infect. 24, 1089\u20131094 (2018).","journal-title":"Clin. Microbiol. Infect."},{"key":"668_CR11","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1001\/jama.2016.4151","volume":"315","author":"KE Fleming-Dutra","year":"2016","unstructured":"Fleming-Dutra, K. E. et al. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010\u20132011. JAMA 315, 1864\u20131873 (2016).","journal-title":"JAMA"},{"key":"668_CR12","doi-asserted-by":"publisher","unstructured":"Miller, K. M. et al. Antibiotic consumption for sore throat and the potential effect of a vaccine against group A Streptococcus: a systematic review and modelling study. SSRN J. https:\/\/doi.org\/10.2139\/ssrn.4344471 (2023).","DOI":"10.2139\/ssrn.4344471"},{"key":"668_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-021-01641-5","volume":"10","author":"DD Barth","year":"2021","unstructured":"Barth, D. D. et al. Modes of transmission and attack rates of group A Streptococcal infection: a protocol for a systematic review and meta-analysis. Syst. Rev. 10, 90 (2021).","journal-title":"Syst. Rev."},{"key":"668_CR14","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/cid\/ciy1143","volume":"69","author":"J Vekemans","year":"2019","unstructured":"Vekemans, J. et al. The path to group A Streptococcus vaccines: World Health Organization research and development technology roadmap and preferred product characteristics. Clin. Infect. Dis. 69, 877\u2013883 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"668_CR15","unstructured":"World Health Organization. WHO Preferred Product Characteristics for Group A Streptococcus Vaccines. https:\/\/apps.who.int\/iris\/handle\/10665\/279142 (2018)."},{"key":"668_CR16","doi-asserted-by":"publisher","first-page":"e957","DOI":"10.1016\/S2214-109X(21)00199-6","volume":"9","author":"MM Coates","year":"2021","unstructured":"Coates, M. M. et al. An investment case for the prevention and management of rheumatic heart disease in the African Union 2021-30: a modelling study. Lancet Glob. Health 9, e957\u2013e966 (2021).","journal-title":"Lancet Glob. Health"},{"key":"668_CR17","doi-asserted-by":"publisher","first-page":"6968","DOI":"10.1016\/j.vaccine.2018.10.001","volume":"36","author":"JW Cannon","year":"2018","unstructured":"Cannon, J. W. et al. An economic case for a vaccine to prevent group A Streptococcus skin infections. Vaccine 36, 6968\u20136978 (2018).","journal-title":"Vaccine"},{"key":"668_CR18","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ijid.2020.11.193","volume":"103","author":"JW Cannon","year":"2021","unstructured":"Cannon, J. W. et al. The economic and health burdens of diseases caused by group A Streptococcus in New Zealand. Int. J. Infect. Dis. 103, 176\u2013181 (2021).","journal-title":"Int. J. Infect. Dis."},{"key":"668_CR19","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2019)."},{"key":"668_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-12040-9","volume":"21","author":"S Echeverria-Londono","year":"2021","unstructured":"Echeverria-Londono, S. et al. How can the public health impact of vaccination be estimated? BMC Public Health 21, 2049 (2021).","journal-title":"BMC Public Health"},{"key":"668_CR21","doi-asserted-by":"publisher","first-page":"101458","DOI":"10.1016\/j.eclinm.2022.101458","volume":"48","author":"KM Miller","year":"2022","unstructured":"Miller, K. M. et al. The global burden of sore throat and group A Streptococcus pharyngitis: a systematic review and meta-analysis. EClinicalMedicine 48, 101458 (2022).","journal-title":"EClinicalMedicine"},{"key":"668_CR22","unstructured":"Carapetis, J. R., Cannon, J. W. & Moore, H. C. A Strategic Approach to Understanding Strep A Disease Burden (SAVAC, 2022)."},{"key":"668_CR23","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators.","year":"2020","unstructured":"GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396, 1204\u20131222 (2020).","journal-title":"Lancet"},{"key":"668_CR24","doi-asserted-by":"publisher","unstructured":"Hutubessy, R. C. W. et al. The full value of vaccine assessments (FVVA): A framework to assess and communicate the value of vaccines for investment and introduction decision making. SSRN J. https:\/\/doi.org\/10.2139\/ssrn.3841999 (2021).","DOI":"10.2139\/ssrn.3841999"},{"key":"668_CR25","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1016\/j.vaccine.2016.03.073","volume":"34","author":"AC Steer","year":"2016","unstructured":"Steer, A. C. et al. Status of research and development of vaccines for Streptococcus pyogenes. Vaccine 34, 2953\u20132958 (2016).","journal-title":"Vaccine"},{"key":"668_CR26","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/INF.0b013e318281da11","volume":"32","author":"AC Steer","year":"2013","unstructured":"Steer, A. C., Dale, J. B. & Carapetis, J. R. Progress toward a global group a Streptococcal vaccine. Pediatr. Infect. Dis. J. 32, 180\u2013182 (2013).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"668_CR27","doi-asserted-by":"crossref","unstructured":"Cadarette, D., Ferranna, M., Cannon, J. & Bloom, D. The Full Health, Economic, and Social Benefits of Strep A Vaccines (SAVAC, 2022).","DOI":"10.1038\/s41541-023-00758-z"},{"key":"668_CR28","doi-asserted-by":"publisher","first-page":"C19","DOI":"10.1016\/j.vaccine.2013.05.045","volume":"31","author":"A Clark","year":"2013","unstructured":"Clark, A. et al. TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination. Vaccine 31, C19\u2013C29 (2013).","journal-title":"Vaccine"},{"key":"668_CR29","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2165\/11539960-000000000-00000","volume":"29","author":"M Jit","year":"2011","unstructured":"Jit, M. & Brisson, M. Modelling the epidemiology of infectious diseases for decision analysis: a primer. Pharmacoeconomics 29, 371\u2013386 (2011).","journal-title":"Pharmacoeconomics"},{"key":"668_CR30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1177\/0272989X02239651","volume":"23","author":"M Brisson","year":"2003","unstructured":"Brisson, M. & Edmunds, W. J. Economic evaluation of vaccination programs: the impact of herd-immunity. Med. Decis. Mak. 23, 76\u201382 (2003).","journal-title":"Med. Decis. Mak."},{"key":"668_CR31","unstructured":"WHO. Bacterial Vaccines in Clinical and Preclinical Development 2021: An Overview and Analysis. https:\/\/www.who.int\/publications\/i\/item\/9789240052451 (2022)."},{"key":"668_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10410","volume":"7","author":"K Korpela","year":"2016","unstructured":"Korpela, K. et al. Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children. Nat. Commun. 7, 10410 (2016).","journal-title":"Nat. Commun."},{"key":"668_CR33","unstructured":"Cadarette, D., Ferranna, M., Cannon, J. & Bloom, D. The full health, economic, and social benefits of Strep A vaccines. https:\/\/savac.ivi.int\/documents\/6.%20The%20full%20health%20economic%20social%20benefits%20of%20vaccination_conceptual%20framework%20and%20application%20to%20Strep%20A%20vaccines_Dan%20Cadarette.pdf (SAVAC, 2022)."},{"key":"668_CR34","unstructured":"UNDP. World Population Prospects\u2014Population Division\u2014United Nations. https:\/\/population.un.org\/wpp\/ (2019)."},{"key":"668_CR35","doi-asserted-by":"publisher","first-page":"e712","DOI":"10.1016\/S2214-109X(15)00069-8","volume":"3","author":"JA Salomon","year":"2015","unstructured":"Salomon, J. A. et al. Disability weights for the global burden of disease 2013 study. Lancet Glob. Health 3, e712\u2013e723 (2015).","journal-title":"Lancet Glob. Health"}],"updated-by":[{"DOI":"10.1038\/s41541-023-00704-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T00:00:00Z","timestamp":1689379200000}}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-023-00668-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-023-00668-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-023-00668-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T17:31:20Z","timestamp":1702575080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-023-00668-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,10]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["668"],"URL":"https:\/\/doi.org\/10.1038\/s41541-023-00668-0","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,10]]},"assertion":[{"value":"28 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41541-023-00704-z","URL":"https:\/\/doi.org\/10.1038\/s41541-023-00704-z","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"90"}}